{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:37:19Z","timestamp":1775155039135,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.prp.2024.155537","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T21:44:26Z","timestamp":1723499066000},"page":"155537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy"],"prefix":"10.1016","volume":"262","author":[{"given":"Kahoko","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waki","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kuraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155537_bib1","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","article-title":"Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival","volume":"19","author":"Halfdanarson","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2024.155537_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","article-title":"Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis","volume":"50","author":"Ito","year":"2015","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.prp.2024.155537_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12020-017-1273-x","article-title":"Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms","volume":"58","author":"Leoncini","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.prp.2024.155537_bib4","unstructured":"Y.J. Ries L.A.G., Keel G.E., Eisner M.P., Lin Y.D., Horner M.-J., Seer Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, Chapter 7 Cancer of the Pancreas Key C, NIH Pub. No. 07-6215 Bethesda, MD, (2007) 59-65."},{"key":"10.1016\/j.prp.2024.155537_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ijc.28400","article-title":"Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms","volume":"134","author":"Woll","year":"2014","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2024.155537_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s43018-022-00344-7","article-title":"Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues","volume":"3","author":"Feng","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.prp.2024.155537_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2021-0428-OA","article-title":"Claudin-18: patterns of expression in the upper gastrointestinal tract and utility as a marker of gastric origin in neuroendocrine tumors","volume":"147","author":"Wong","year":"2022","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2024.155537_bib8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1083\/jcb.125.6.1353","article-title":"Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine","volume":"125","author":"Berndorff","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.prp.2024.155537_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/dvdy.1146","article-title":"LI-cadherin gene expression during mouse intestinal development","volume":"221","author":"Angres","year":"2001","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.prp.2024.155537_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/gut.49.1.73","article-title":"R. Gessner, LI-cadherin: a marker of gastric metaplasia and neoplasia","volume":"49","author":"Grotzinger","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.prp.2024.155537_bib11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/ar.20597","article-title":"Claudin-7 expressed on lateral membrane of rat epididymal epithelium does not form aberrant tight junction strands","volume":"290","author":"Inai","year":"2007","journal-title":"Anat. Rec."},{"key":"10.1016\/j.prp.2024.155537_bib12","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1128\/MCB.21.21.7380-7390.2001","article-title":"claudin-18, a novel downstream target gene for the T\/EBP\/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing","volume":"21","author":"Niimi","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.prp.2024.155537_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/path.1922","article-title":"Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype","volume":"208","author":"Sanada","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2024.155537_bib14","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1158\/1078-0432.CCR-08-1547","article-title":"Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development","volume":"14","author":"Sahin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2024.155537_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/his.14358","article-title":"Colitis-associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy","volume":"79","author":"Iwaya","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155537_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00428-021-03207-1","article-title":"Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status","volume":"480","author":"Asaka","year":"2022","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2024.155537_bib17","article-title":"Targeting CLDN18.2 in cancers of the gastrointestinal tract: new drugs and new indications","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2024.155537_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/annonc\/mdz199","article-title":"A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study","volume":"30","author":"Tureci","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2024.155537_bib19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.annonc.2021.02.005","article-title":"FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma","volume":"32","author":"Sahin","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2024.155537_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jnci\/djy134","article-title":"Claudin18.2-specific chimeric antigen receptor engineered T cells for the treatment of gastric cancer","volume":"111","author":"Jiang","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2024.155537_bib21","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3390\/jcm9061894","article-title":"CAR-T cell therapy-an overview of targets in gastric cancer","volume":"9","author":"Bebnowska","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.prp.2024.155537_bib22","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2024.155537_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/his.12535","article-title":"Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour","volume":"66","author":"Johnson","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155537_bib24","unstructured":"WHO Classification of Tumours Editorial Bord. Digestive System Tumours, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas 69372 Lyon Cedex 08, France, 2019."},{"key":"10.1016\/j.prp.2024.155537_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","article-title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor","volume":"51","author":"Tanigawa","year":"2018","journal-title":"Med Mol. Morphol."},{"key":"10.1016\/j.prp.2024.155537_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000334269","article-title":"Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm","volume":"79","author":"Morimatsu","year":"2012","journal-title":"Pathobiology"},{"key":"10.1016\/j.prp.2024.155537_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/his.12610","article-title":"Expression of cadherin 17 in well-differentiated neuroendocrine tumours","volume":"66","author":"Snow","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155537_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s001250050693","article-title":"Proliferation and differentiation in the human fetal endocrine pancreas","volume":"40","author":"Bouwens","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.prp.2024.155537_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4132\/jptm.2014.10.23","article-title":"Clinical and prognostic significances of Cytokeratin 19 and KIT expression in surgically resectable pancreatic neuroendocrine tumors","volume":"49","author":"Son","year":"2015","journal-title":"J. Pathol. Transl. Med"},{"key":"10.1016\/j.prp.2024.155537_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187588","article-title":"Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: a meta-analysis","volume":"12","author":"Cen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2024.155537_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.5834","article-title":"Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors","volume":"256","author":"Dreijerink","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2024.155537_bib32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/PAS.0b013e31815701f3","article-title":"New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8","volume":"32","author":"Karanjawala","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155537_bib33","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1369\/0022155411420569","article-title":"Claudin-18 is an early-stage marker of pancreatic carcinogenesis","volume":"59","author":"Tanaka","year":"2011","journal-title":"J. Histochem Cytochem"},{"key":"10.1016\/j.prp.2024.155537_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5858\/arpa.2011-0326-OA","article-title":"Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas","volume":"136","author":"Liu","year":"2012","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2024.155537_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jclinpath-2011-200400","article-title":"Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation","volume":"65","author":"Soini","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2024.155537_bib36","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/bjs.8843","article-title":"Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma","volume":"99","author":"Bartsch","year":"2012","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.prp.2024.155537_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00000658-198809000-00006","article-title":"Outcome of lymph node involvement in patients with the Zollinger-Ellison syndrome","volume":"208","author":"Delcore","year":"1988","journal-title":"Ann. Surg."},{"key":"10.1016\/j.prp.2024.155537_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000098009","article-title":"Gastrinoma (duodenal and pancreatic","volume":"84","author":"Jensen","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.prp.2024.155537_bib39","unstructured":"NIH, A phase 1\/2 study to evaluate CHM-2101, an autologous cadherin 17 chimeric antigen receptor (CAR) T cell therapy. ClinicalTrials.gov. Updated September 26, 2023. Accessed November 6, 2023. https:\/\/clinicaltrials.gov\/study\/NCT06055439."},{"key":"10.1016\/j.prp.2024.155537_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/MPA.0000000000001597","article-title":"The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors","volume":"49","author":"Halfdanarson","year":"2020","journal-title":"Pancreas"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824004485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824004485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:12:31Z","timestamp":1727187151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824004485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":40,"alternative-id":["S0344033824004485"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155537","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155537"}}